Evidence map›Paper›PMID 42423923›Full record

ArticleMolecular diversity2026

Heterogeneous dual-channel and interpretable graph representation learning with global virtual nodes for microRNA-mediated drug sensitivity prediction.

Kailai Zhou, Jinming Guo, Yang Cao, Ziqi Xu, Yanbu Guo

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kailai ZhouCollege of Software Engineering, Zhengzhou University of Light Industry, Zhengzhou, 450000, China.
Jinming GuoCollege of Software Engineering, Zhengzhou University of Light Industry, Zhengzhou, 450000, China.
Yang CaoSchool of Cyber Science and Engineering, Southeast University, Nanjing, 211189, China. caoyeacy@seu.edu.cn.
Ziqi XuSchool of Chemistry and Materials Science, Nanjing Normal University, Nanjing, 210023, China.
Yanbu GuoCollege of Software Engineering, Zhengzhou University of Light Industry, Zhengzhou, 450000, China. guoyanbu@gmail.com.

Funding

Basic Science (Natural Science) Research Project of Colleges and Universities in Jiangsu Province 25KJB150020Fundamental Research Funds for the Central Universities 2242025K30025National Natural Science Foundation of China 22504063National Natural Science Foundation of China 62403437National Natural Science Foundation of China 62573122Natural Science Foundation of Jiangsu Province BK20231112Open Research Project of the Key Laboratory of Numerical Simulation for Large-Scale Complex Systems, Ministry of Education NSLSCS202502Open Research Project of the State Key Laboratory of Industrial Control Technology ICT2025B37Science and Technology Project of Henan Province 252102210154
6 · The paper itself

Abstract

Drug sensitivity critically affects therapeutic outcomes, and microRNAs (miRNAs) play a key role in regulating drug response by modulating genes involved in drug metabolism and action. However, existing computational methods for predicting miRNA-drug sensitivity associations are often limited by heterogeneous network structures and severe data sparsity, which hinder effective feature propagation and robust learning. To address these challenges, we propose HDIGRL, a channel-aware heterogeneous graph representation learning framework centered on channel-gated global heterogeneous propagation for miRNA-mediated drug sensitivity prediction. HDIGRL models miRNAs and drugs from complementary structural and interaction-derived perspectives via a dual-channel feature extraction strategy. HDIGRL introduces channel-gated global heterogeneous propagation, in which global virtual nodes first enable graph-level context exchange and a channel-wise propagation gate then recalibrates propagated embeddings to emphasize discriminative feature channels and suppress noisy or redundant ones. In addition, an imbalance-aware focal loss is adopted to improve robustness under extreme class imbalance. Experimental results on public datasets demonstrate that HDIGRL consistently outperforms existing methods, and further analyses reveal latent miRNA-mediated drug-sensitivity pathways, highlighting its potential for predictive modeling and biological interpretation.

Indexed as

Complex networksGlobal virtual nodesHeterogeneous networksmiRNA-drug sensitivity

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.